ducovest

FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 11.62

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

N/A

 CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

 CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

 CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

N/A

 CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

 CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

 CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

 CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

 CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

 CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

 CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.06% 13% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.06% 12% F 15% F
Trailing 12 Months  
Capital Gain -6.37% 9% A- 17% F
Dividend Return 1.76% 47% F 32% F
Total Return -4.61% 9% A- 16% F
Trailing 5 Years  
Capital Gain 2.02% 33% F 33% F
Dividend Return 32.29% 88% B+ 76% C+
Total Return 34.31% 40% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 3.73% 54% F 48% F
Dividend Return 4.45% 53% F 44% F
Total Return 0.72% 67% D+ 29% F
Risk Return Profile  
Volatility (Standard Deviation) 5.00% 79% B- 91% A-
Risk Adjusted Return 88.94% 91% A- 88% B+
Market Capitalization 0.05B 44% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.